Patents by Inventor GOPALA KRISHNA DASARI

GOPALA KRISHNA DASARI has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11111250
    Abstract: The present invention relates to novel crystalline and amorphous polymorphic forms of Ribociclib(1) mono succinate. (I) Said crystalline forms may be useful in the improved preparation of oral dosage forms for the treatment of cancer.
    Type: Grant
    Filed: December 20, 2018
    Date of Patent: September 7, 2021
    Assignee: SHILPA MEICARE LIMITED
    Inventors: Sriram Rampalli, Lav Kumar Upalla, Suryanarayan Cherukuvada, Chanti Babu Patneedi, Gopala Krishna Dasari, Vijaya Murali Mohan Rao Seshagiri
  • Publication number: 20200339588
    Abstract: The present invention relates to novel crystalline and amorphous polymorphic forms of Ribociclib(1) mono succinate. (I) Said crystalline forms may be useful in the improved preparation of oral dosage forms for the treatment of cancer.
    Type: Application
    Filed: December 12, 2018
    Publication date: October 29, 2020
    Applicant: SHILPA MEDICARE LIMITED
    Inventors: SRIRAM RAMPALLI, LAV KUMAR UPALLA, SURYANARAYAN CHERUKUVADA, CHANTI BABU PATNEEDI, GOPALA KRISHNA DASARI, VIJAYA MURALI MOHAN RAO SESHAGIRI
  • Patent number: 10435409
    Abstract: The present invention relates to a process for the preparation of 1-[(3R)-3-[4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl]-1-piperidinyl]-2-propen-1-one or Ibrutinib of Formula (I). The present invention further relates to a process for the preparation highly pure 1-[(3R)-3-[4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl]-1-piperidinyl]-2-propen-1-one or Ibrutinib(I).
    Type: Grant
    Filed: February 2, 2017
    Date of Patent: October 8, 2019
    Assignee: SHILPA MEDICARE LIMITED
    Inventors: Sriram Rampalli, Lav Kumar Upalla, Chanti Babu Patneedi, Gopala Krishna Dasari, Akshay Kant Chaturvedi
  • Publication number: 20190040069
    Abstract: The present invention relates to a process for the preparation of 1-[(3R)-3-[4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl]-1-piperidinyl]-2-propen-1-one or Ibrutinib of Formula (I).
    Type: Application
    Filed: February 2, 2017
    Publication date: February 7, 2019
    Applicant: SHILPA MEDICARE LIMITED
    Inventors: SRIRAM RAMPALLI, LAV KUMAR UPALLA, CHANTI BABU PATNEEDI, GOPALA KRISHNA DASARI, AKSHAY KANT CHATURVEDI